[Expression and significance of IGF-1R and VEGF in gastric carcinoma].
Weidong Liu, Ren Yu, Guan-rong Zhou
Abstract
Weidong Liu, Ren Yu, Guan-rong Zhou
Abstract
AIM: To analyze the expression of IGF-1R and VEGF in human gastric carcinoma, and evaluate the relationship between their expression and tumor's invasion and metastasis. METHODS: 56 cases with gastric carcinoma, 20 cases of atypical hyperplasia tissues of adjacent carcinoma and 28 normal gastric mucosa membrane tissues were examined for the expression of IGF-1R and VEGF by SABC immunohistochemistry. RESULTS: The positive rates of IGF-1R protein in gastric carcinoma tissues, atypical hyperplasia tissues of adjacent carcinoma and normal gastric mucosa membrane tissues are 87.50%, 55.00% and 17.86%, respectively, and the difference between any two groups was significant (P<0.01); the positive rates of IGF-1R protein in the tissues of metastasis and non-metastasis are 97.06% and 72.73%, respectively(P<0.05); the positive rates of IGF-1R protein in the gastric carcinoma tissues of invaded submucosa, muscular and outer layers are 66.67%, 92.59% and 100%, respectively (P<0.05). The positive rates of VEGF protein in gastric carcinoma tissues, atypical hyperplasia tissues of adjacent carcinoma and normal gastric mucosa are 69.64%, 45.00% and 25.00%, respectively, and the difference between any two groups is significant (P<0.05); the positive rates of VEGF protein in the tissues of metastasis and non-metastasis are 85.29% and 45.45%, respectively (P<0.01); the positive rates of VEGF protein in the gastric carcinoma tissues of invaded submucosa, muscular and outer layers are 40.00%, 74.07% and 85.71%, respectively (P<0.05). CONCLUSION: The results suggest that the expression of IGF-1R or VEGF may be related to the development, invasion and metastasis of gastric carcinoma.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To analyze the expression of IGF-1R and VEGF in human gastric carcinoma, and evaluate the relationship between their expression and tumor's invasion and metastasis. METHODS: 56 cases with gastric carcinoma, 20 cases of atypical hyperplasia tissues of adjacent carcinoma and 28 normal gastric mucosa membrane tissues were examined for the expression of IGF-1R and VEGF by SABC immunohistochemistry. RESULTS: The positive rates of IGF-1R protein in gastric carcinoma tissues, atypical hyperplasia tissues of adjacent carcinoma and normal gastric mucosa membrane tissues are 87.50%, 55.00% and 17.86%, respectively, and the difference between any two groups was significant (P<0.01); the positive rates of IGF-1R protein in the tissues of metastasis and non-metastasis are 97.06% and 72.73%, respectively(P<0.05); the positive rates of IGF-1R protein in the gastric carcinoma tissues of invaded submucosa, muscular and outer layers are 66.67%, 92.59% and 100%, respectively (P<0.05). The positive rates of VEGF protein in gastric carcinoma tissues, atypical hyperplasia tissues of adjacent carcinoma and normal gastric mucosa are 69.64%, 45.00% and 25.00%, respectively, and the difference between any two groups is significant (P<0.05); the positive rates of VEGF protein in the tissues of metastasis and non-metastasis are 85.29% and 45.45%, respectively (P<0.01); the positive rates of VEGF protein in the gastric carcinoma tissues of invaded submucosa, muscular and outer layers are 40.00%, 74.07% and 85.71%, respectively (P<0.05). CONCLUSION: The results suggest that the expression of IGF-1R or VEGF may be related to the development, invasion and metastasis of gastric carcinoma.
Key concepts: Submucosa, Immunohistochemistry, Metastasis, Gastric carcinoma, Pathology, Atypical hyperplasia, Carcinoma, Hyperplasia